As of 2026-10-14, the Relative Valuation of Bright Minds Biosciences Inc (DRUG.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 77.10 CAD, the upside of Bright Minds Biosciences Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2026-10-09 | -30.86 |
| 2026-10-08 | -29.43 |
| 2026-10-07 | -29.44 |
| 2026-10-06 | -27.70 |
| 2026-10-05 | -29.03 |
| 2026-10-02 | -28.25 |
| 2026-10-01 | -28.39 |
| 2026-09-30 | -28.15 |
| 2026-09-29 | -28.53 |
| 2026-09-28 | -29.38 |
| 2026-09-25 | -29.59 |
| 2026-09-24 | -31.33 |
| 2026-09-23 | -32.64 |
| 2026-09-22 | -34.69 |
| 2026-09-21 | -33.76 |
| 2026-09-17 | -34.22 |
| 2026-09-16 | -32.95 |
| 2026-09-15 | -33.51 |
| 2026-09-14 | -35.65 |
| 2026-09-11 | -35.38 |
| 2026-09-10 | -35.51 |
| 2026-09-09 | -36.03 |
| 2026-09-08 | -36.71 |
| 2026-09-04 | -36.86 |
| 2026-09-03 | -37.74 |
| 2026-09-02 | -39.65 |
| 2026-09-01 | -39.11 |
| 2026-08-31 | -39.43 |
| 2026-08-28 | -40.67 |
| 2026-08-27 | -41.20 |
| 2026-08-26 | -42.84 |
| 2026-08-25 | -43.94 |
| 2026-08-24 | -43.16 |
| 2026-08-21 | -43.29 |
| 2026-08-20 | -43.79 |
| 2026-08-18 | -45.91 |
| 2026-08-17 | -43.28 |
| 2026-08-14 | -42.96 |
| 2026-08-13 | -43.92 |
| 2026-08-12 | -44.71 |
| 2026-08-11 | -45.01 |
| 2026-08-10 | -45.34 |
| 2026-08-07 | -44.44 |
| 2026-08-06 | -45.63 |
| 2026-08-05 | -43.85 |
| 2026-08-04 | -43.75 |
| 2026-07-31 | -41.28 |
| 2026-07-30 | -41.81 |
| 2026-07-29 | -39.87 |
| 2026-07-28 | -40.51 |